CHroniSense National Early Warning Score Study

NAUnknownINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

June 30, 2018

Primary Completion Date

June 30, 2019

Study Completion Date

November 30, 2019

Conditions
Clinical Assessment
Interventions
DEVICE

Polso Wearebale watch

The objective of the Polso™ feasibility study is to demonstrate the suitability of Polso™ as a data acquisition and processing platform by comparison with the conventional British version of EWS (UK-NEWS) on aggregate and on each individual parameter score. Although in a full NEWS system, the frequency of testing is determined by the score itself, this aspect will not be evaluated, in the event that a divergence of scores would complicate clinical evaluation and correspondence of readings. In addition, good clinical practice calls for patient care to be fully motivated by the NEWS currently in use, as opposed to the experimental Polso™. Therefore, this compromise will be made, which will still permits system evaluation.

Sponsors

Lead Sponsor

All Listed Sponsors
lead

BlueWind Medical

INDUSTRY

NCT03448861 - CHroniSense National Early Warning Score Study | Biotech Hunter | Biotech Hunter